miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
Br J Cancer
; 123(3): 426-437, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32418991
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein Kinases
/
Repressor Proteins
/
Breast Neoplasms
/
Biomarkers, Tumor
/
Down-Regulation
/
MicroRNAs
Limits:
Female
/
Humans
Language:
En
Journal:
Br J Cancer
Year:
2020
Document type:
Article
Affiliation country: